| Dr Marshall Hutchison, DO | |
|
5001 Hardy St, Hattiesburg, MS 39402-1308 | |
| (601) 296-3963 | |
| Not Available |
| Full Name | Dr Marshall Hutchison |
|---|---|
| Gender | Male |
| Speciality | Radiology - Vascular & Interventional Radiology |
| Location | 5001 Hardy St, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447783717 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 31375 (Mississippi) | Primary |
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
In celebration of World Sleep Day, Royal Philips today released its report, "Unfiltered Sleep: A Global Prioritization Puzzle," which showcases the results of an international survey conducted online in February by Harris Poll on behalf of Philips.
BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
With today's announcement of guidelines for the new Patient's Bill of Rights, the Democratic-led Congress and the Obama Administration are upholding our pledge of greater access, affordability, and reliability in Americans' insurance coverage. And we are fulfilling the core promises of health reform: to protect patients, strengthen our middle class and small businesses, and put Americans and their doctor – not insurance company bureaucrats — in charge of medical care.
Promethera Biosciences, a company that develops innovative therapies for the treatment of liver diseases, today announces a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism.
› Verified 1 days ago
| Entity Name | Comprehensive Radiology Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992731590 PECOS PAC ID: 1759364946 Enrollment ID: O20040609000828 |
News Archive
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
In celebration of World Sleep Day, Royal Philips today released its report, "Unfiltered Sleep: A Global Prioritization Puzzle," which showcases the results of an international survey conducted online in February by Harris Poll on behalf of Philips.
BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
With today's announcement of guidelines for the new Patient's Bill of Rights, the Democratic-led Congress and the Obama Administration are upholding our pledge of greater access, affordability, and reliability in Americans' insurance coverage. And we are fulfilling the core promises of health reform: to protect patients, strengthen our middle class and small businesses, and put Americans and their doctor – not insurance company bureaucrats — in charge of medical care.
Promethera Biosciences, a company that develops innovative therapies for the treatment of liver diseases, today announces a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marshall Hutchison, DO 26851 Standard Dedeaux Rd, Kiln, MS 39556-6204 Ph: (228) 324-1265 | Dr Marshall Hutchison, DO 5001 Hardy St, Hattiesburg, MS 39402-1308 Ph: (601) 296-3963 |
News Archive
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
In celebration of World Sleep Day, Royal Philips today released its report, "Unfiltered Sleep: A Global Prioritization Puzzle," which showcases the results of an international survey conducted online in February by Harris Poll on behalf of Philips.
BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
With today's announcement of guidelines for the new Patient's Bill of Rights, the Democratic-led Congress and the Obama Administration are upholding our pledge of greater access, affordability, and reliability in Americans' insurance coverage. And we are fulfilling the core promises of health reform: to protect patients, strengthen our middle class and small businesses, and put Americans and their doctor – not insurance company bureaucrats — in charge of medical care.
Promethera Biosciences, a company that develops innovative therapies for the treatment of liver diseases, today announces a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism.
› Verified 1 days ago
Dr. Craig S Howard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Cleveland Alexander Hudson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Sophy H Mangana, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-1700 Fax: 601-288-1715 | |
Dr. Naim Joseph Salloum, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-1700 Fax: 601-288-1715 | |
Dr. Neil J Solomon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Richard F Mccarthy, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Steven G Cunningham, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 |